Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Boston Scientific Corporation

Boston Scientific Corporation (BSX-PA) Stock Overview

Explore Boston Scientific Corporation’s financial performance, market position, analyst ratings, and future outlook.

BSX-PA●NYSE
HealthcareMedical - Devices
$122.18
$2.83(2.37%)
U.S. Market opens in 2h 54m

Boston Scientific Corporation (BSX-PA)

Meyka AI Score

Z

Key Financials

Market Cap175.4B
P/E Ratio20.91
EPS (TTM)$0.53
ROE0.15%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$121.18

BSX-PA Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Boston Scientific Corporation (NYSE: BSX-PA) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Boston Scientific Corporation's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of BSX-PA on the NYSE shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $121.18 for the NYSE listing.

Key metrics behind Boston Scientific Corporation's NYSE-traded stock include a P/E ratio of 20.91 and a market capitalization of 175.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BSX-PA on the NYSE.

Price Performance (NYSE: BSX-PA)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.37%
3-Month Change
2.23%
6-Month Change
6.41%
Year-to-Date (YTD) Change
7.18%
1-Year Change
20.45%
3-Year Change
16.71%
5-Year Change
17.48%
All-Time (Max) Change
17.48%

Contact Information

https://www.bostonscientific.com
508 683 4000
300 Boston Scientific Way, Marlborough, MA, 01752-1234

Company Facts

450,000 Employees
IPO DateMay 22, 2020
CountryUS

Frequently Asked Questions